The VICC.ORG Directory of Cancers: Treatments, Services & Resources
Lung and Thoracic Cancers
Types of Lung Cancer
Lung Cancer News
Clinical Trials for Lung Cancers
25 Open Trials
| Trial Type & Disease | Protocol No. & Open Date | Summary |
|---|---|---|
| Therapeutic Non Small Cell | VICCTHO1042 10/11/2011 | A Phase 1-2 Trial of MM-121 in Combination with Erlotinib in Three Groups of Patients with Non-Small Cell Lung Cancer |
| Therapeutic Non Small Cell | VICCTHO1079 07/27/2011 | Phase 3, Randomized, Open-Label Study of the Efficacy and Safety of Crizotinib versus Pemetrexed/Cisplatin or Pemetrexed/Carboplatin in Previously Untreated Patients with Non-Squamous Carcinoma of the Lung Harboring a Translocation or Inversion Event Involving the Anaplastic Lymphoma Kinase (ALK) Gene Locus |
| Therapeutic Non Small Cell | VICCTHO1097 07/11/2011 | A Randomized, Double-Blind, Phase 2 Study of Erlotinib (Tarceva) in Combination with OSI-906 or Placebo in Chemonaive Patients with Advanced NSCLC with Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene |
| Therapeutic Lung; Non Small Cell | ECOGTHNE5508 06/29/2011 | Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Premetrexed, or Combination of Bevacizumab and Premtrexed following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC |
| Therapeutic Breast; Esophageal; Gastric/Gastroesophageal; Head/Neck; Non Small Cell; Small Cell | VICCGI1068 06/08/2011 | A Phase I Dose Escalation Study of MLN8237, an Aurora A Kinase Inhibitor, in Adult Patients with Nonhematological Malignancies, Followed by a Phase 2 of MLN8237 in Lung, Breast, Head and Neck, or Gastroesophageal Malignancies |
| Therapeutic Non Small Cell | ECOGTHO5508-M 02/09/2011 | Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC |
| Therapeutic Lung | ECOGTHO4508-M 12/07/2010 | Three-Arm Randomized Phase II Study of Carboplatin and Paclitaxel in Combination with Cetuximab, IMC-A12 or Both for Advanced Non-small Cell Lung Cancer Patients WhoWill Not Receive Bevacizumab-based Therapy |
| Therapeutic Lung; Non Small Cell | ACOSOGTHOC140503 09/15/2010 | A Phase III Randomized Trial of Lobectomy versus Sublobar Resection for Small (less than or equal to 2 cm) Peripheral Non-Small Cell Lung Cancer |
| Therapeutic Lung; Non Small Cell | VICCTHO09103 09/08/2010 | A Phase Ib Open-Label Clinical Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 Plus Cetuximab (Erbitux) in Patients with Non-Small Cell Lung Cancer with Progression Following Prior Erlotinib (Tarceva) or Gefitinib (Iressa) |
| Therapeutic Head/Neck; Lung; Non Small Cell | VICCHN0908 03/12/2010 | Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family Kinases Using Erlotinib and Dasatinib in Head and Neck and Lung Cancers. |
| Therapeutic Lung | CTSUTHOC30607-M 02/17/2010 | ARandomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Patients following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer |
| Therapeutic Lung; Non Small Cell | VICCTHO0730 10/15/2007 | A Phase II Trial of Celecoxib plus Chemotherapy [Docetaxel or Pemetrexed] in Patients with Previously Treated, "COX Dependent" Recurrent Non-Small Cell Lung Cancer (SPORE) |
| Therapeutic Lung; Non Small Cell | ECOGTHOE1505 08/30/2007 | A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (>=4 cm)-IIIA Non-Small Cell Lung Cancer (NSCLC). |
| Therapeutic Non Small Cell | ECOGTHOE1505-M 07/27/2007 | A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB (> or = 4 cm)- IIIA Non-Small Cell Lung Cancer (NSCLC) |
| Correlative Lung; Non Small Cell | VICCTHN1167 03/02/2012 | A Prospective Study to Evaluate the Concordance of Tumor-Associated EGFR Mutations Detected in Matched Tumor and Blood Samples in Patients with NSCLC |
| Correlative Lung; Non Small Cell | VICCTHN1164 11/04/2011 | Molecular Profiles for Lung Cancer Pathogenesis and Detection |
| Correlative Lung; Small Cell | VICCTHO09110 05/31/2011 | Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network |
| Correlative Lung; Non Small Cell | VICCTHO0547 12/19/2005 | Molecular Fingerprints in Lung Cancer: Predicting Tumor Response to Therapy (SPORE) |
| Correlative Lung | VICCTHO0398 12/04/2003 | Molecular Predictors of Lung Cancer Behavior. (SPORE) |
| Correlative Lung | VICCTHO0373 05/03/2001 | Identification and Validation of Molecular Markers in Lung Cancer (SPORE) |
| Correlative Non Small Cell | VICCTHO0136 05/01/2001 | Molecular Fingerprinting of Lung Cancer (SPORE) |
| Epidemiology, Observation, Outcomes Breast; Colon; Lung; Rectal | VICCREACH1113 05/10/2011 | Formative Research Needs to Address the Differing Needs of Cancer Survivors (Pilot #1 of the MMC and VICC Partnering for Survivorship Project) |
| Epidemiology, Observation, Outcomes Breast - Female; Colon; Lung; Prostate; Rectum | VICCREACH1086P20PILOT2-M 02/23/2011 | Assessing the needs for Cancer Survivors |
| Epidemiology, Observation, Outcomes Lung; Non Small Cell | VICCTHO0938 07/13/2009 | Survey and Blood Sample Collection for Patients with Lung Cancer Who Never Smoked Cigarettes. |
| Screen, Detect, Diagnose Lung; Miscellaneous | VICCTHO1078 04/12/2011 | Nashville Early Diagnosis Lung Cancer Project |
You do not have JavaScript enabled. This site works better with JavaScript turned on.
